| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.33 | 0.02 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.16 | 0.02 |